Creative Planning Teva Pharmaceutical Industries LTD Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

A detailed history of Creative Planning transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Creative Planning holds 42,815 shares of TEVA stock, worth $749,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,815
Previous 40,952 4.55%
Holding current value
$749,262
Previous $665,000 15.94%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$15.81 - $18.96 $29,454 - $35,322
1,863 Added 4.55%
42,815 $771,000
Q2 2024

Aug 15, 2024
SELL
$12.78 - $17.4 $7,259 - $9,883
-568 Reduced 1.37%
40,952 $665,000
Q1 2024

May 10, 2024
SELL
$10.67 - $14.43 $17,733 - $23,982
-1,662 Reduced 3.85%
41,520 $585,000
Q4 2023

Feb 14, 2024
SELL
$8.12 - $10.63 $8,712 - $11,405
-1,073 Reduced 2.42%
43,182 $450,000
Q3 2023

Nov 16, 2023
SELL
$7.48 - $10.7 $235,253 - $336,525
-31,451 Reduced 41.54%
44,255 $451,000
Q2 2023

Jul 21, 2023
BUY
$7.2 - $9.47 $24,948 - $32,813
3,465 Added 4.8%
75,706 $570,000
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $31,115 - $42,319
-3,722 Reduced 4.9%
72,241 $639,000
Q4 2022

Feb 10, 2023
BUY
$7.95 - $9.48 $13,984 - $16,675
1,759 Added 2.37%
75,963 $692,000
Q3 2022

Nov 03, 2022
BUY
$6.86 - $11.95 $40,755 - $70,994
5,941 Added 8.7%
74,204 $599,000
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $69,431 - $97,843
9,408 Added 15.99%
68,263 $513,000
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $189,253 - $242,440
-25,819 Reduced 30.49%
58,855 $553,000
Q4 2021

Feb 11, 2022
SELL
$7.9 - $10.19 $29,285 - $37,774
-3,707 Reduced 4.19%
84,674 $678,000
Q3 2021

Nov 10, 2021
SELL
$8.38 - $10.18 $243,388 - $295,667
-29,044 Reduced 24.73%
88,381 $861,000
Q2 2021

Aug 04, 2021
SELL
$9.9 - $11.56 $526,076 - $614,286
-53,139 Reduced 31.15%
117,425 $1.16 Million
Q1 2021

Apr 30, 2021
BUY
$10.34 - $12.81 $172,088 - $213,196
16,643 Added 10.81%
170,564 $1.97 Million
Q4 2020

Jan 29, 2021
BUY
$8.61 - $11.04 $9,384 - $12,033
1,090 Added 0.71%
153,921 $1.49 Million
Q3 2020

Nov 05, 2020
BUY
$8.57 - $12.69 $211,379 - $312,998
24,665 Added 19.24%
152,831 $1.38 Million
Q2 2020

Jul 23, 2020
SELL
$8.12 - $13.12 $922,196 - $1.49 Million
-113,571 Reduced 46.98%
128,166 $1.58 Million
Q1 2020

May 05, 2020
SELL
$6.69 - $13.45 $370,204 - $744,282
-55,337 Reduced 18.63%
241,737 $2.17 Million
Q4 2019

Jan 30, 2020
SELL
$6.53 - $10.72 $426,996 - $700,980
-65,390 Reduced 18.04%
297,074 $2.91 Million
Q3 2019

Nov 01, 2019
BUY
$6.16 - $9.6 $1.1 Million - $1.71 Million
178,022 Added 96.52%
362,464 $2.49 Million
Q2 2019

Jul 26, 2019
BUY
$8.12 - $15.72 $533,013 - $1.03 Million
65,642 Added 55.25%
184,442 $1.7 Million
Q1 2019

Apr 24, 2019
BUY
$15.58 - $20.01 $130,685 - $167,843
8,388 Added 7.6%
118,800 $1.86 Million
Q4 2018

Feb 01, 2019
SELL
$14.59 - $23.84 $1.33 Million - $2.17 Million
-91,032 Reduced 45.19%
110,412 $1.7 Million
Q3 2018

Oct 25, 2018
BUY
$21.06 - $25.65 $695,527 - $847,116
33,026 Added 19.61%
201,444 $4.34 Million
Q2 2018

Jul 20, 2018
SELL
$16.77 - $24.71 $390,254 - $575,026
-23,271 Reduced 12.14%
168,418 $4.1 Million
Q1 2018

Apr 18, 2018
BUY
$16.68 - $22.07 $240,508 - $318,227
14,419 Added 8.13%
191,689 $3.28 Million
Q4 2017

Jan 17, 2018
SELL
$11.23 - $19.1 $923,543 - $1.57 Million
-82,239 Reduced 31.69%
177,270 $3.36 Million
Q3 2017

Oct 17, 2017
BUY
$15.41 - $32.17 $4 Million - $8.35 Million
259,509
259,509 $4.57 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email